These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29209450)

  • 1. Zinc chelation promotes streptokinase-induced thrombolysis
    Wang Z; Yu X; Li YV
    Int J Physiol Pathophysiol Pharmacol; 2017; 9(5):137-146. PubMed ID: 29209450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metal ion chelation enhances tissue plasminogen activator (tPA)-induced thrombolysis: an in vitro and in vivo study.
    Yu X; Wang Z; Li YV
    J Thromb Thrombolysis; 2022 Feb; 53(2):291-301. PubMed ID: 34757546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in thrombolytic therapy.
    Collen DC; Gold HK
    Thromb Res Suppl; 1990; 10():105-31. PubMed ID: 2180114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
    Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
    Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis.
    Ouriel K; Welch EL; Shortell CK; Geary K; Fiore WM; Cimino C
    J Vasc Surg; 1995 Nov; 22(5):593-7. PubMed ID: 7494361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism].
    Mühl D
    Orv Hetil; 2008 May; 149(20):935-48. PubMed ID: 18467263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of tissue plasminogen activator and streptokinase magnetic nanoparticles to target vascular diseases.
    Tadayon A; Jamshidi R; Esmaeili A
    Int J Pharm; 2015 Nov; 495(1):428-438. PubMed ID: 26363110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; del Zoppo G; Yamaguchi T
    Cochrane Database Syst Rev; 2000; (2):CD000213. PubMed ID: 10796329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.
    Agnelli G; Buchanan MR; Fernandez F; Boneu B; Van Ryn J; Hirsh J; Collen D
    Circulation; 1985 Jul; 72(1):178-82. PubMed ID: 4039986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers.
    Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P
    J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolysis for acute ischaemic stroke.
    Wardlaw JM; Zoppo G; Yamaguchi T; Berge E
    Cochrane Database Syst Rev; 2003; (3):CD000213. PubMed ID: 12917889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distributed intraclot thrombolysis: mechanism of accelerated thrombolysis with encapsulated plasminogen activators.
    Leach JK; Patterson E; O'Rear EA
    J Thromb Haemost; 2004 Sep; 2(9):1548-55. PubMed ID: 15333029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Angiographic Study of Intracoronary Streptokinase versus Intravenous Tissue Plasminogen Activator After Failed Coronary Thrombolysis with Intravenous Streptokinase.
    Verheugt FW; Veen G; de Cock CC ; Meijer A
    J Thromb Thrombolysis; 1996; 3(3):239-243. PubMed ID: 10613987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in clot lysis among patients demonstrated in vitro with three thrombolytic agents (tissue-type plasminogen activator, streptokinase and urokinase).
    Musselman DR; Tate DA; Oberhardt BJ; Abruzzini AF; Blauwet MB; Koch G; Dehmer GJ
    Am J Cardiol; 1994 Mar; 73(8):544-9. PubMed ID: 8147298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of a plasminogen activator speeds reperfusion, lessens infarct and reduces blood loss in a canine model of coronary artery thrombosis.
    Leach JK; Patterson E; O'Rear EA
    Thromb Haemost; 2004 Jun; 91(6):1213-8. PubMed ID: 15175809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New thrombolytic agents. Effect on the organization of care in myocardial infarction].
    Castaigne A; Duval-Moulin AM; Dubois Rande JL; Hervé C
    Ann Cardiol Angeiol (Paris); 1987 Dec; 36(10):577-81. PubMed ID: 3434985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.
    Barbash GI; Birnbaum Y; Bogaerts K; Hudson M; Lesaffre E; Fu Y; Goodman S; Houbracken K; Munsters K; Granger CB; Pieper K; Califf RM; Topol EJ; Van De Werf F
    Circulation; 2001 Feb; 103(7):954-60. PubMed ID: 11181469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.